Age, Gender and Geographic Differences in Global Health Burden of Cirrhosis and Liver Cancer due to Nonalcoholic Steatohepatitis.
Age, Gender and Geographic Differences in Global Health Burden of Cirrhosis and Liver Cancer due to Nonalcoholic Steatohepatitis.
复制标题
非酒精性脂肪性肝炎导致的肝硬化和肝癌全球健康负担的年龄、性别和地理差异
DOI:
10.7150/jca.52282
复制
发表时间:
2021
影响因子:
3.9
通讯作者:
Shan PF
中科院分区:
文献类型:
--
作者:
Zhang T;Xu J;Ye L;Lin X;Xu Y;Pan X;Weng X;Ye C;Fan L;Ren Y;Shan PF
Objective: Recently, Nonalcoholic Steatohepatitis (NASH) has become a major contributor to cirrhosis and liver cancer. Therefore, the Global Burden of Disease (GBD) 2017 was used to comprehensively analyze the global, regional, and national burden of cirrhosis and liver cancer due to NASH between 1990 and 2017. Methods: Data for cirrhosis and liver cancer due to NASH were extracted from the GBD study 2017. Socio-demographic Index (SDI) in 2017 was cited as indicators of socioeconomic status. ARIMA model was established to forecast the future health burden. Kruskal-Wallis test and Pearson linear correlation were adopted to evaluate the gender disparity and association with socioeconomic level. Results: From 1990-2017, the global disability-adjusted life years (DALYs) numbers of liver cancer due to NASH increased from 0.71 million to 1.46 million. The age-standardized DALYs rates of liver cancer due to NASH were negatively associated with SDI levels (r=0.-409, p<0.001). Geographically, Australasia experienced the largest increase in the burden of liver cancer due to NASH, with the age-standardized DALYs rate increasing by 143.54%. The global prevalence number of liver cancer due to NASH peaked at 60-64 years in males and at 65-69 years in females. Globally, the burden was heavier in males compared with females. Male-female-ratio of age-standardized DALYs rates in liver cancer due to NASH were positively related to SDI (r=0.303, P=0.011). Conclusion: The global burden of NASH-associated liver cancer has increased significantly since 1990, with age, gender and geographic disparity. Public awareness of liver diseases due to NASH should be emphasized.
登录
查看更多内容
DOI:
10.1016/s0140-6736(18)31694-5
发表时间:
2018-11-10
期刊:
Lancet (London, England)
影响因子:
--
作者:
Foreman KJ;Marquez N;Dolgert A;Fukutaki K;Fullman N;McGaughey M;Pletcher MA;Smith AE;Tang K;Yuan CW;Brown JC;Friedman J;He J;Heuton KR;Holmberg M;Patel DJ;Reidy P;Carter A;Cercy K;Chapin A;Douwes-Schultz D;Frank T;Goettsch F;Liu PY;Nandakumar V;Reitsma MB;Reuter V;Sadat N;Sorensen RJD;Srinivasan V;Updike RL;York H;Lopez AD;Lozano R;Lim SS;Mokdad AH;Vollset SE;Murray CJL
通讯作者:
Murray CJL
DOI:
10.1016/s0140-6736(18)32225-6
发表时间:
2018-11-10
期刊:
Lancet (London, England)
影响因子:
--
作者:
GBD 2017 Risk Factor Collaborators
通讯作者:
GBD 2017 Risk Factor Collaborators
影响因子:
3.8
作者:
Ballestri S;Nascimbeni F;Baldelli E;Marrazzo A;Romagnoli D;Lonardo A
通讯作者:
Lonardo A
影响因子:
13.5
作者:
Sanyal, Arun J.;Harrison, Stephen A.;Goodman, Zachary
通讯作者:
Goodman, Zachary
影响因子:
10.3
作者:
Pan, Wen-Chi;Wu, Chih-Da;Yang, Hwai-I
通讯作者:
Yang, Hwai-I